H.R.4373, Further Additional Continuing Appropriations and Extensions Act, 2023 Trade-related aspects of Intellectual Property (TRIPS) Waiver, no related bill number Issues related to tax reform and tax policy Implementation of Tax Cuts and Jobs Act of 2017 (P.L.115-97) International tax issues, including Pillar 1 and Pillar 2 Drug cost and pricing policy Patient affordability issues policy proposals related to clinical trial diversity Issues related to the 340B program Drug cost and pricing policy issues Issues regarding coverage, coding, and reimbursement issues Issues regarding Alzheimer's treatments Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, PET scan coverage and reimbursement, and dementia care H.R.19, Lower Costs, More Cures Act of 2021 H.R. 5376, Inflation Reduction Act, including provisions related to corporate taxes, Medicare, and prescription drug pricing H.R.7667, Food and Drug Amendments of 2022 User Fee Agreements, specifically reauthorization of PDUFA and BSUFA Aduhelm National Coverage Determination
BUD - Budget/Appropriations TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code PHA - Pharmacy MMM - Medicare/Medicaid HCR - Health Issues
1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
JONATHAN CAUSEY DANIEL HARDER DANIEL HARDER KATHLEEN KONKA AARON NICHOLAS BADIDA DANIEL HARDER JONATHAN CAUSEY KATHLEEN KONKA DANIEL HARDER KATHLEEN KONKA TYLER HANSON DANIEL HARDER ALI LAKHANI JOHN RAYMOND GIBSON JONATHAN CAUSEY